Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-12 09:11 am Purchase |
2023-12-31 | 13G | Akoya Biosciences, Inc. AKYA |
PSC Capital Partners LLC | 3,517,360 7.200% |
800,000 (+29.44%) |
Filing History |
| 2023-02-15 09:15 am Unchanged |
2022-12-31 | 13G | Akoya Biosciences, Inc. AKYA |
PSC Capital Partners LLC | 2,717,360 7.200% |
0 (Unchanged) |
Filing History |
| 2023-02-14 3:47 pm Sale |
2022-12-31 | 13G | Akoya Biosciences, Inc. AKYA |
PSC Capital Partners LLC | 2,717,360 7.200% |
-96,411 (-3.43%) |
Filing History |
| 2022-02-25 10:57 am Purchase |
2021-12-31 | 13G | Akoya Biosciences, Inc. AKYA |
PSC Capital Partners LLC | 2,813,771 7.600% |
2,813,771 (New Position) |
Filing History |
| 2022-02-14 12:56 pm Purchase |
2021-12-31 | 13G | Akoya Biosciences, Inc. AKYA |
PSC Capital Partners LLC | 2,813,771 7.600% |
2,813,771 (New Position) |
Filing History |